Please use this identifier to cite or link to this item:
Authors: Fraungruber, Patricia
Kaltofen, Till
Heublein, Sabine
Kuhn, Christina
Mayr, Doris
Burges, Alexander
Mahner, Sven
Rathert, Philipp
Jeschke, Udo
Trillsch, Fabian
Title: G protein-coupled estrogen receptor correlates with Dkk2 expression and has prognostic impact in ovarian cancer patients
Issue Date: 2021 Zeitschriftenartikel 8 Frontiers in endocrinology 12 (2021), No. 564002
ISSN: 1664-2392
Abstract: Wnt pathway modulator Dickkopf 2 (Dkk2) and signaling of the G protein-coupled estrogen receptor (GPER) seem to have essential functions in numerous cancer types. For epithelial ovarian cancer (EOC), it has not been proven if either Dkk2 or the GPER on its own have an independent impact on overall survival (OS). So far, the correlation of both factors and their clinical significance has not systematically been investigated before. Expression levels of Dkk2 were immunohistochemically analyzed in 156 patient samples from different histologic subtypes of EOC applying the immune-reactivity score (IRS). Expression analyses were correlated with clinical and pathological parameters to assess for prognostic relevance. Data analysis was performed using Spearman’s correlations, Kruskal-Wallis-test and Kaplan-Meier estimates. Highest Dkk2 expression of all subtypes was observed in clear cell carcinoma. In addition, Dkk2 expression differed significantly (p<0.001) between low and high grade serous ovarian cancer. A significant correlation of Dkk2 with the cytoplasmic GPER expression was noted (p=0.001) but not for the nuclear estrogen receptor alpha (ERα) or beta (ERβ). Patients exhibiting both, high expression Dkk2 (IRS>4) and GPER (IRS>8), had a significantly better overall survival compared to patients with low expression (61 months vs. 33 months; p=0.024). Dkk2 and GPER expression correlates in EOC and combined expression of both is associated with improved OS. These findings underline the clinical significance of both pathways and indicate a possible prognostic impact as well as a potential for treatment strategies addressing interactions between estrogen and Wnt signaling in ovarian cancer.
Appears in Collections:03 Fakultät Chemie

Files in This Item:
File Description SizeFormat 
fendo-12-564002.pdf1,46 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons